An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Paragon 28, Inc. (FNA) to present at 42nd Annual J.P. Morgan Healthcare Conference
Positive
None.
Negative
None.
ENGLEWOOD, Colo.--(BUSINESS WIRE)--
Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 3:00 p.m. Pacific Time / 4:00 p.m. Mountain Time.
A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.
About Paragon 28, Inc.
Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.
Investor Contact:
Matt Brinckman
Senior Vice President, Strategy and Investor Relations
(720) 912-1332
mbrinckman@paragon28.com
Source: Paragon 28, Inc.
FAQ
What is the latest announcement from Paragon 28, Inc. (FNA)?
Paragon 28, Inc. (FNA) announced that their Chairman and CEO, Albert DaCosta, and CFO, Steve Deitsch, will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference.
When and where will the presentation take place?
The presentation will take place on Monday, January 8, 2024, at 3:00 p.m. Pacific Time / 4:00 p.m. Mountain Time.
Where can I watch the live webcast and archived recording of the presentation?
The live webcast and archived recording will be available on the investor relations section of the Company’s website at ir.paragon28.com.
